Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
HIV/AIDS Conferences
Upcoming Conferences

May 24-27
Miami, Fla.
24th Annual National Conference on Social Work and HIV/AIDS

May 30 - June 1
Madrid, Spain
8th International Workshop on HIV & Hepatitis Coinfection

June 3-5
Miami Beach, Fla.
7th International Conference on HIV Treatment and Prevention Adherence

More upcoming HIV/AIDS meetings >>

Conference Calendar
2012
MAY JUNE
JULY AUG.
SEP. OCT.
NOV. DEC.

The Body's Conference Coverage
CROI 2012
HIV TREATMENT & HEALTH ISSUES: Oral Cancer More Common Among HIV-Infected North Americans

HIV PREVENTION: Mixed Findings Paint a Tricky Picture for HIV Serosorting and Other Seroadaptive Behaviors

HIV TREATMENT & HEALTH ISSUES: Life Expectancy Increases for North Americans Living With HIV

HIV VACCINES: Inching Forward With HIV Vaccines: Digesting Envelope Decoys

More from CROI 2012 >>

 

CROI 2011
HIV/AIDS TREATMENT STRATEGIES: Could MicroRNA Be the Next Great Frontier in HIV/AIDS Treatment -- and Prevention?

COMPLICATIONS & COINFECTIONS: The Slow Decline: An Update on Neurological Complications Among People With HIV

HIV/AIDS TREATMENT STRATEGIES: Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient?

HIV TREATMENT & HEALTH ISSUES: Studies in Post-Menopausal Women Reveal Potentially Higher Biological HIV Risk, as Well as Possible Tenofovir Concerns

More from CROI 2011 >>
ICAAC 2011
HIV/AIDS TREATMENT STRATEGIES: Sangamo's SB-728 HIV Gene Therapy Approach Still Looks Sexy, but Leaves More Questions Than Answers

DRUGS IN DEVELOPMENT: Ibalizumab Study Casts a Ray of Hope for HIV-Infected People With Extensive Drug Resistance

CLINICAL DEVELOPMENTS: ICAAC HIV Poster Roundup #1: Clinically Relevant Findings

CLINICAL DEVELOPMENTS: ICAAC HIV Poster Roundup #2: Clinically Relevant Findings

More from ICAAC 2011 >>

 

ICAAC 2010
HIV/AIDS TREATMENT STRATEGIES: Once-Daily "Extended" Formulation of Nevirapine Holds Up Well in 48-Week Study Results

DRUGS IN DEVELOPMENT: "Quad" Pill Continues to Impress in Week-48 Results; Cobicistat Moves Forward in Battle With Ritonavir

HIV/AIDS TREATMENT STRATEGIES: A Slice of Atazanavir, but Hold the Ritonavir: Switch to Unboosted Dose Still Effective After 120 Weeks, With Good Lipid Findings

COMPLICATIONS & COINFECTIONS: Even Among Long-Term HIV Nonprogressors, Some Signs of Heightened Cardiovascular Risk Exist, U.S. Study Finds

More from ICAAC 2010 >>

 

Past Conference Coverage
Advertisement